Similarly, in retinoblastoma, elevated PRMT1 expression promotes Y79 cell proliferation via the p53/p21/CDC2/cyclin B pathway, whereas PRMT1 silencing inhibits cell growth [79]. Here, PRMT1 is linked to retinoblastoma.